Kubota Pharmaceutical will sell specially designed glasses dubbed Kubota Glass, which it claims are able to reverse the effects of myopia.
The glasses shine tiny lights at the retina to simulate short-distance blurring, forcing the user to look further ahead and in doing so taking the pressure of the axial deformation of eyeballs.
Long-term testing is still required to gauge how effective Kubota Glass is at this in detail, but studies so far suggest that they are at least effective at curbing the progression of myopia.
Kubota Glass has been approved as a medical device in Taiwan and the USA.
Kubota Pharmaceutical charges 770,000 yen for a pair of Kubota Glass while offering a 100-percent satisfaction guarantee.
According to 2009 research conducted by Japan's Ministry of Education, Culture, Sports, Science, and Technology, around 25% of first-graders had less than perfect eyesight, with the percentage rising to 50% among sixth-graders.


China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Tabletop particle accelerator could transform medicine and materials science
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
White House Seeks $87.6 Billion Emergency Funding for Iran War, Farmers, and Ebola Response
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Morgan Stanley Sees Chinese Auto Market Recovery Gaining Momentum in Late Summer
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow 



